l.aaltonen
TL3 Regular · Rimini, IT
Clinician. Posts general information only, and says so every time.
Joined 4 January 2025 · last posted 1d · groups: clinicians
136 posts, newest first. Showing up to 150.
-
Endotoxin and why it is a separate question from purity — what changed since Replied, post #91 · Analytics › Impurities & related substances · 27 Jul 2026 · 0 likes Agreed on Endotoxin, with one qualification that I think matters. The reasoning holds for the case as described. Change the starting assumption and it does not, and the…
-
Muscle cramps: the ordinary causes before the exotic ones — a second dataset Replied, post #61 · Practice › Side effects · 19 Jul 2026 · 6 likes The useful distinction on Muscle cramps is between what was measured and what was inferred from it. Both end up in the same sentence and only one of them has error bars.
-
Tracking a shortage from primary sources rather than rumour Replied, post #111 · Access › Shortages · 19 Jul 2026 · 2 likes Post #107 describes the usual case. This is about the unusual one. Switching presentation or strength during a shortage is a prescribing decision rather than a…
-
Tirzepatide storage and stability: what is published versus what is assumed Replied, post #21 · Compounds › Tirzepatide · 16 Jul 2026 · 32 likes The five maintenance doses in the tirzepatide programme give a genuine dose-response curve, which is unusual. Most trials in this space compare one or two doses against…
-
Distinguishing a red flag from an inconvenience — a second dataset Started this topic · Sourcing › Red flags · 16 Jul 2026 · 1 like On the subject in the title: Distinguishing a red flag from an inconvenience — a second dataset Working notes rather than a conclusion. Posting a small dataset on…
-
Insurance and replacement policies, compared Replied, post #89 · Sourcing › Logistics · 15 Jul 2026 · 7 likes Adding the measurement that post #86 says would settle it. Document outcomes rather than forecasting them. A forecast in this category reads as reassurance and is not…
-
Revisiting: Journal club: SURMOUNT-OSA and a hard endpoint in a soft field Replied, post #101 · Evidence › Journal club · 12 Jul 2026 · 0 likes The baseline characteristics table is the single most useful page for the questions that get asked here, because it tells you who the result applies to.
-
Impurity thresholds: where the common numbers come from Replied, post #3 · Analytics › Impurities & related substances · 12 Jul 2026 · 3 likes Deamidation at asparagine or glutamine adds approximately one dalton and frequently produces a close-eluting pair. It is the impurity most likely to be integrated into…
-
[2026 update] Travelling with an injectable: documentation and practicalities Replied, post #68 · Access › International · 9 Jul 2026 · 5 likes Licensed prescribing: where a compound is approved, prescribing is restricted to licensed prescribers. Where it is not approved, the legality of possession and use is…
-
Second pass at: Cost versus information: making the trade-off explicitly Replied, post #18 · Analytics › Home & field testing · 9 Jul 2026 · 0 likes Distinguishing three things in the Cost versus information discussion that keep getting used interchangeably: the observation, the proposed mechanism, and the…
-
Coming back to: A structured critique template this community uses Replied, post #53 · Evidence › Study critique · 8 Jul 2026 · 5 likes One more thing on structured critique template that took me far too long to see: the two figures people quote are not measuring the same quantity. Once you notice that,…
-
How much context is too much context in a first post? Replied, post #33 · Start Here › How to Ask · 7 Jul 2026 · 9 likes When you quote a figure from somewhere else, say where from. Not as a formality — the answer frequently depends on whether the number came from a certificate, an…
-
Reading a rodent study on a secretagogue without over-extrapolating — the long version Replied, post #22 · Compounds › Secretagogues & GH axis · 4 Jul 2026 · 11 likes The version of Reading a rodent study that I was taught turned out to be a teaching simplification. Useful, and not true in the way I had assumed it was.
-
Coming back to: Why a preprint's supplementary material is often the best part Replied, post #96 · Evidence › Preprints · 4 Jul 2026 · 4 likes Post #94 is the version of this I will quote in future. One addition. Sample size and pre-registration are checkable in a preprint exactly as in a paper, and they carry…
-
Restarting after a long gap: what the labelling implies Replied, post #7 · Practice › Dosing & titration · 30 Jun 2026 · 16 likes Marking my place. If it changes for me I will come back and say so.
-
Journal club: what we got wrong in an earlier session Replied, post #30 · Evidence › Journal club · 26 Jun 2026 · 6 likes Noted, and I have changed what I was going to do on the strength of it.
-
Sample size intuition for a personal experiment — does this still hold? Replied, post #36 · Research Methods › Statistics · 25 Jun 2026 · 18 likes Effect sizes: the magnitude of a difference, not just whether it is statistically significant. A difference that is significant (p Written quickly, so the reasoning may…
-
I joined for one answer and stayed for a year — what changed my mind Replied, post #39 · Start Here › Welcome · 24 Jun 2026 · 10 likes Marked solutions are the site's way of saying that someone asked a good question and someone else gave an answer that actually worked. It is not a competition and it…
-
Revisiting: Protein density versus volume when you cannot eat much Replied, post #4 · Nutrition & Training › Protein & intake · 23 Jun 2026 · 8 likes Adding the measurement that the opening post says would settle it. Temperature and texture change what is tolerable for a lot of people during the first weeks, and that…
-
CJC-1295 with and without DAC: what the modification does Replied, post #89 · Compounds › Secretagogues & GH axis · 20 Jun 2026 · 2 likes Reconstitution volumes in this family are often small enough that dead volume in the syringe is a meaningful fraction of the dose. A fixed-needle insulin syringe is…
-
Revisiting: Bioimpedance and hydration: why the number moves Replied, post #3 · marked as the solution · Outcomes › Body composition · 19 Jun 2026 · 10 likes Where a facility reports a precision figure for its own machine, that number is more useful than any published average. This is the sort of thing the wiki should carry…
-
Injecting into an area that has become firm: why not to Replied, post #64 · Practice › Administration · 13 Jun 2026 · 1 like Following this. I have the same question and no better information than the first post.
-
A 5 mg vial and a 0.25 mg dose: the arithmetic in full Replied, post #80 · Practice › Reconstitution · 12 Jun 2026 · 26 likes Nothing to add, except that this is the answer I would give if asked.
-
Reading U-100 graduations, with a conversion table Replied, post #32 · Devices › Syringes & needles · 8 Jun 2026 · 4 likes Source for the reading U-100 graduations figure, since it was asked for. It is in the discussion rather than the abstract, which is why the version circulating is…
-
Injecting into an area that has become firm: why not to Replied, post #28 · Practice › Administration · 7 Jun 2026 · 7 likes Letting a refrigerated preparation come to room temperature before injecting reduces the sting for most people. It is not a stability requirement, it is a comfort one,…
-
A certificate whose chromatogram axes do not match its stated method — one year on Replied, post #21 · Sourcing › Red flags · 3 Jun 2026 · 28 likes What I would tell a new member reading about certificate whose chromatogram axes for the first time: the confident posts are not the reliable ones, and the reliable…
-
Comparing prices across jurisdictions without misleading yourself Replied, post #24 · Access › Pricing · 31 May 2026 · 1 like Post #23 is right about the mechanism and I think understates the practical bit. The site carries no prices, no payment routes and no supplier links beyond the…
-
A parcel stationary at a customs facility for nine days — does this still hold? Replied, post #24 · Sourcing › Logistics · 31 May 2026 · 30 likes This follows post #21 rather than contradicting it. The useful distinction on parcel stationary is between what was measured and what was inferred from it. Both end up…
-
Analytical identity of BPC-157: a 15-mer with a simple mass — does this still hold? Replied, post #26 · Compounds › Repair & healing peptides · 20 May 2026 · 7 likes The pentadecapeptide sequence is short and stable enough to survive conditions that would degrade a larger peptide, which is one of the few things about it that is well…
-
Journal club: LEADER as the historical anchor Replied, post #75 · Evidence › Journal club · 17 May 2026 · 27 likes On LEADER I would separate what is worth knowing from what is worth acting on. The first list is long and the second is short, and conflating them is how threads get…
-
Semaglutide and gastric emptying — the mechanism behind most of the side-effect profile Replied, post #28 · Compounds › Semaglutide · 16 May 2026 · 11 likes Research-use-only semaglutide is not a licensed medicine, is not manufactured to pharmaceutical standards, and is not approved for human use. That is a statement about…
-
Journal club: orforglipron phase 2 and the non-peptide question Replied, post #61 · Evidence › Journal club · 12 May 2026 · 0 likes That reframing is the whole thing. The facts I already had.
-
Molecular mass of semaglutide and why the figure differs between sources Replied, post #54 · Compounds › Semaglutide · 11 May 2026 · 4 likes Semaglutide versus liraglutide in STEP 8: semaglutide produced greater weight reduction and the discontinuation rates differed. But the trial was open-label for the…
-
What a good consultation looks like from the other side Replied, post #39 · Clinical › Prescriber conversations · 10 May 2026 · 19 likes Post #35 describes the usual case. This is about the unusual one. The failure mode on good consultation is boring rather than dramatic. It is almost always the step…
-
[2026 update] Does a peptide degrade silently, with no visual change? Replied, post #55 · Practice › Storage & stability · 4 May 2026 · 0 likes Two questions I would want answered before drawing anything from the peptide data above: how were the cases selected, and what happened to the ones that dropped out.
-
[2026 update] Storing lyophilised material long term: what governs the shelf life Replied, post #109 · Practice › Storage & stability · 3 May 2026 · 0 likes Acknowledging rather than arguing. The reasoning holds as far as I can follow it.
-
Citation sweep results: how many references did not say what was claimed Replied, post #86 · Meta › Wiki maintenance · 29 Apr 2026 · 16 likes Good question, well framed, and I would like to see it answered properly.
-
Subgroup analyses: pre-specified versus discovered — a second dataset Replied, post #59 · Evidence › Trials · 25 Apr 2026 · 17 likes Post #55 put the caveat in the right place and I want to underline it. Absolute numbers, not just relative: a 30% relative reduction tells you the ratio but not the…
-
Spike-and-recover accuracy for a peptide assay Replied, post #59 · Analytics › Method validation · 9 Apr 2026 · 31 likes The limit of quantitation determines what the impurity table can honestly contain. Peaks below it can be reported as detected and cannot be reported as a number. I…
-
Bug report: the reconstitution calculator and a rounding edge case Replied, post #54 · Data & Tools › Calculators · 8 Apr 2026 · 5 likes No disagreement from me. Posting only so the question does not look ignored.
-
[2026 update] Hello from a laboratory that does not do peptides Replied, post #3 · Lounge › Introductions · 6 Apr 2026 · 13 likes Say hello. No question required. Introduce yourself if you want to give context for why you are here, or just introduce yourself because you like meeting people. I am…
-
Specificity, linearity, accuracy, precision, range, robustness — with real criteria Replied, post #4 · Analytics › Method validation · 4 Apr 2026 · 2 likes Adding thanks rather than a view. I do not have a view worth the space.
-
Reused chromatograms across lots: how to spot it Replied, post #30 · Analytics › COA interpretation · 30 Mar 2026 · 29 likes Post #26 put the caveat in the right place and I want to underline it. On reused chromatograms across lots the community has more anecdote than the confidence in this…
-
Air bubbles in a subcutaneous injection: the honest risk assessment — does this still… Replied, post #26 · Practice › Administration · 24 Mar 2026 · 2 likes Post #22 and I disagree about the size of the effect, not about the direction. Careful with the language on Air bubbles. "Not detected" and "not present" are different…
-
[2026 update] Confounding by indication, explained with a concrete example Replied, post #76 · Evidence › Study critique · 22 Feb 2026 · 0 likes Building consensus on which criticisms matter: if everyone agrees that the sample size is small but only you think that affects the conclusion, maybe your criticism is…
-
Dizziness on standing and the electrolyte explanation — does this still hold? Replied, post #47 · Practice › Side effects · 17 Feb 2026 · 8 likes Same experience here, different supplier, so it is at least not unique to one of them.
-
Mass error in ppm: the arithmetic and the caveat Replied, post #126 · Analytics › Mass spectrometry · 16 Feb 2026 · 0 likes Quantitation by MS: most quantitation is done by LC-UV detection at 214 nm, not by MS, because extinction coefficients are better known. MS can quantify if an internal…
-
Pharmacy supply in the UK and the questions you will be asked Replied, post #41 · Regional › UK & Ireland · 14 Feb 2026 · 9 likes Private prescribing is legal and widespread, including through remote consultation. Pharmacies must satisfy themselves that a prescription is clinically appropriate.…
-
Second pass at: Choosing a concentration on purpose rather than by accident Replied, post #9 · Practice › Reconstitution · 9 Feb 2026 · 8 likes I had written a reply contradicting post #5 and deleted it. Here is what survived. On a U-100 insulin syringe, one hundred units is one millilitre and one unit is 0.01…
-
Pharmacy supply in the UK and the questions you will be asked Replied, post #34 · Regional › UK & Ireland · 8 Feb 2026 · 16 likes Nothing in this subcategory is medical or legal advice, and prescribers reading here consistently say so themselves.
-
[2026 update] What a purity-only report leaves out Replied, post #17 · Sourcing › Independent verification · 5 Feb 2026 · 11 likes Confirming post #16 from a second method, which matters more than confirming it from a second person. A record with four results over sixteen months is a thin record…
-
Non-inferiority margins: how they are chosen and how they are abused — a second dataset Replied, post #17 · Evidence › Trials · 29 Jan 2026 · 4 likes The reason Non-inferiority margins keeps being re-asked is that the answer is conditional and people quote it without the condition. It is not that the answer is unknown.
-
Coming back to: Reading a supplier's product description as a marketing document Replied, post #6 · Compounds › Other compounds · 25 Jan 2026 · 2 likes Several compounds discussed here have no published human pharmacokinetics at all. That means half-life claims in circulation were derived from an animal model or from…
-
Storing lyophilised material long term: what governs the shelf life Replied, post #21 · Practice › Storage & stability · 10 Jan 2026 · 31 likes Picking up post #20: that is the part I would want checked first. An observation about storing lyophilised material long term that I cannot explain and am posting…
-
Distinguishing expected GI effects from something that needs urgent attention Replied, post #27 · Practice › Side effects · 4 Jan 2026 · 4 likes Everything in post #25 holds. The case it does not cover is the one I have. The published rates come from populations that were titrated on a defined schedule with…
-
Reverse causation in a cohort study of weight and outcome Replied, post #14 · Evidence › Study critique · 3 Jan 2026 · 3 likes This follows post #11 rather than contradicting it. An update on my earlier reverse causation post: the pattern held for another six weeks and then stopped, which I did…
-
What "verified" means on our vendor pages, stated narrowly Replied, post #14 · Sourcing › Vendor reports · 27 Dec 2025 · 25 likes I will take the caveat as seriously as the claim, which is the point of putting it there.
-
Substitution between formats during a shortage Replied, post #120 · Access › Shortages · 20 Dec 2025 · 27 likes Where a shortage forces a gap, the pharmacokinetics mean a missed week is a perturbation rather than a reset, which is worth knowing.
-
Tracking a preprint to publication: a worked example Replied, post #119 · Evidence › Preprints · 12 Dec 2025 · 0 likes This settles it for me, at least until somebody posts a reason it should not.
-
Robustness: the parameters worth deliberately varying Replied, post #47 · Analytics › Method validation · 7 Dec 2025 · 2 likes I would be cautious about generalising from the robustness example above. It is a good example. It is one example.
-
Journal club: LEADER as the historical anchor Replied, post #9 · Evidence › Journal club · 3 Dec 2025 · 0 likes A definition problem is doing most of the work in this LEADER discussion. Once the term is pinned down I suspect the disagreement mostly goes away and what is left is…
-
[2026 update] How much of the diluent volume the powder itself displaces Replied, post #49 · Practice › Reconstitution · 25 Nov 2025 · 8 likes Do not shake. Swirl, or leave it. Vigorous agitation introduces air and shear, and neither helps a peptide go into solution any faster than patience does. That is the…
-
Long-time reader, first-time poster Replied, post #16 · Lounge › Introductions · 14 Nov 2025 · 1 like Adding a reference point for long-time reader. Mine is a single case, collected without controls, and I am posting the method alongside it so it can be discounted…
-
Adolescents: a distinct evidence base — one year on Replied, post #33 · Clinical › Special populations · 12 Nov 2025 · 0 likes I read post #32 twice before replying, because I had assumed the opposite. A request rather than an answer: could whoever has the primary source for Adolescents post…
-
The anatomy of a question that gets answered within an hour — the long version Replied, post #80 · Start Here › How to Ask · 10 Nov 2025 · 16 likes Context that matters: compound, how long in, current dose, relevant history. Context that does not matter: how you feel, your hopes for the outcome, your medical…
-
Why "any advice?" is the least effective ending for a post — the long version Replied, post #81 · Start Here › How to Ask · 5 Nov 2025 · 0 likes Understood, and I withdraw the assumption I opened with.
-
Comparing my trajectory with the trial curves, carefully Replied, post #71 · Outcomes › Progress reports · 4 Nov 2025 · 0 likes Answering the question post #67 raises rather than the one it answers. Non-scale victories: muscle gain or maintenance, clothing fit, energy level, and capability (like…
-
EMA product information as a primary source Replied, post #18 · Regional › European Union · 31 Oct 2025 · 7 likes Confirming post #17 from a second method, which matters more than confirming it from a second person. The version of EMA product information that I was taught turned…
-
Liver enzymes drifting down and what that usually means Replied, post #22 · Clinical › Bloodwork · 26 Oct 2025 · 15 likes Glycaemic markers integrate over different periods. A point glucose and a longer-term marker disagreeing is not a contradiction; it is two different questions. Adding…
-
Coming back to: Why quantitation is the hard part, not detection Replied, post #82 · Analytics › Home & field testing · 21 Oct 2025 · 5 likes Everything in post #80 holds. The case it does not cover is the one I have. The right question for any home test is: what physical quantity does it measure, and what…
-
What happens after your first post: likes, trust levels, and why none of it matters much… Replied, post #67 · Start Here › Welcome · 18 Oct 2025 · 9 likes The Lounge is a real category rather than a dumping ground. The sourcing rule still applies there, which surprises people, but the register is looser and nobody minds a…
-
The most useful thing you learned here that was not the answer you came for — a second… Replied, post #68 · Lounge › Off topic · 1 Oct 2025 · 10 likes Agreed, and the corollary is that a place with no visible corrections is not a place with fewer errors.
-
Pinch or no pinch, and how needle length changes the answer Replied, post #76 · Practice › Administration · 24 Sep 2025 · 0 likes No notes. Posting so the count is not one.
-
Reverse causation in a cohort study of weight and outcome — a second dataset Replied, post #22 · Evidence › Study critique · 13 Sep 2025 · 0 likes This follows post #21 rather than contradicting it. Attrition is the failure mode most likely to invalidate a result and the least likely to be discussed. Differential…
-
Reverse causation in a cohort study of weight and outcome — a second dataset Replied, post #13 · Evidence › Study critique · 12 Sep 2025 · 9 likes Reverse causation would be much easier to settle if anyone reported the denominator. Almost nobody reports the denominator.
-
Power cut for eleven hours: how I assessed it afterwards Replied, post #47 · Practice › Storage & stability · 6 Sep 2025 · 0 likes Something worth flagging about power cut for eleven hours: the strongest-sounding claims in this thread are the ones with no source attached, which is the usual pattern…
-
[2026 update] Does dual agonism explain the effect size, or is it dose? Replied, post #12 · Compounds › Tirzepatide · 4 Sep 2025 · 20 likes Post #11 answers the question as asked. The question underneath it is different. Worth separating dual agonism as a question about the compound from dual agonism as a…
-
Coming back to: Resolution and tailing factor: real acceptance criteria Replied, post #52 · Analytics › HPLC & UHPLC · 29 Aug 2025 · 14 likes Reading rather than contributing, but this is the most useful thread I have found on it.
-
Reading a rodent study on a secretagogue without over-extrapolating Replied, post #40 · Compounds › Secretagogues & GH axis · 26 Aug 2025 · 6 likes Genuine question rather than a rhetorical one: has anyone here actually observed reading a rodent study, as opposed to read about it? The thread is long and I cannot…
-
Follow-up: Glucagon receptor agonism in a weight-loss compound Replied, post #4 · Pharmacology › Receptor biology · 24 Aug 2025 · 31 likes Receptor distribution explains the side-effect profile better than anything else. GLP-1 receptors in the gastrointestinal tract and the area postrema account for most…
-
Which panel is worth repeating and which is worth ignoring Replied, post #90 · Clinical › Bloodwork · 21 Aug 2025 · 1 like Repeat before acting is standard practice for an isolated abnormal result on most analytes, and it is standard for a reason.
-
What a documentation review can and cannot tell you Replied, post #76 · Sourcing › Independent verification · 16 Aug 2025 · 23 likes This follows post #75 rather than contradicting it. Source for the documentation review figure, since it was asked for. It is in the discussion rather than the…
-
Are there stupid questions here? A staff answer, at length Replied, post #60 · Start Here › Welcome · 11 Aug 2025 · 0 likes I will take the caveat as seriously as the claim, which is the point of putting it there.
-
Second pass at: What "verified" means on our vendor pages, stated narrowly Replied, post #6 · Sourcing › Vendor reports · 9 Aug 2025 · 9 likes Adding the measurement that post #3 says would settle it. Dosing and purity: a vial that is 99% pure might contain 80% of its label claim if the other mass is water,…
-
Lyophilisation and why the cake looks the way it does Replied, post #11 · Pharmacology › Formulation chemistry · 7 Aug 2025 · 10 likes Where I part company with post #9, and it is a narrow parting. Bulking agents such as mannitol give the cake structure and contribute to the mass in the vial. Their…
-
A ten-fold dose error caught before injection — one year on Replied, post #61 · Devices › Syringes & needles · 2 Aug 2025 · 5 likes The arithmetic in post #60 is right; the assumption feeding it is the part to check. Barrel size determines resolution and nothing else. A 0.3 mL barrel and a 1 mL…
-
Revisiting: Reading a denial letter as a specification for your appeal Replied, post #48 · Access › Insurance & coverage · 18 Jul 2025 · 0 likes Denial letters: the stated reason tells you exactly what to submit next. A denial is not final; it is a specification for an appeal. Reading the reason carefully and…
-
Revisiting: What to include when your question involves arithmetic Replied, post #20 · Start Here › How to Ask · 14 Jul 2025 · 0 likes A photograph of a vial is rarely useful and a photograph of a document usually is. Redact the identifiers before you post either. I would not lead a decision with this,…
-
A field-by-field walk through a certificate of analysis Replied, post #7 · Analytics › COA interpretation · 14 Jul 2025 · 0 likes Post #4 is right about the mechanism and I think understates the practical bit. Reading old certificates: if a certificate is dated years ago, the lot it describes…
-
Forced degradation studies: designing one that is informative — does this still hold? Replied, post #30 · Analytics › Method validation · 4 Jul 2025 · 28 likes The arithmetic in post #27 is right; the assumption feeding it is the part to check. Where a pharmacopoeial monograph exists, a method that follows it inherits a great…
-
A 10 mg vial reconstituted three different ways, compared — the long version Replied, post #80 · Practice › Reconstitution · 3 Jul 2025 · 10 likes Worth separating two things that post #76 runs together. Why "add 2 mL" is not an instruction: the powder in the vial takes up space. "Add 2 mL to a 10 mL vial" and…
-
BPC-157: what the rodent literature actually shows, and what it does not — a second… Replied, post #63 · Compounds › Repair & healing peptides · 27 Jun 2025 · 5 likes The absence of adequately powered published randomised human trials is the central fact about BPC-157. This site states that plainly rather than hedging. Mechanistic…
-
Asking about a compound your prescriber has not heard of Replied, post #76 · Clinical › Prescriber conversations · 25 Jun 2025 · 1 like Post #75 and I disagree about the size of the effect, not about the direction. Bringing a record of symptoms with dates and severities makes an assessment materially…
-
Area percent versus weight percent: the confusion that causes most arguments — what… Replied, post #14 · Analytics › HPLC & UHPLC · 24 Jun 2025 · 15 likes System suitability testing: injections run before and during the sample run to establish whether the instrument, column and method were performing when the sample was…
-
Random versus fixed effects: choosing rather than defaulting Replied, post #4 · Evidence › Meta-analyses · 14 Jun 2025 · 23 likes Pooled estimates and heterogeneity: when trials differ in population, duration, or comparator, a pooled estimate answers a question that no individual trial asked. High…
-
Coming back to: Getting a referral rather than a refusal Replied, post #68 · Clinical › Prescriber conversations · 14 Jun 2025 · 0 likes Where the Getting a referral discussion usually stalls is that nobody wants to say "I do not know" and everyone is willing to say "it varies". Those are the same…
-
[2026 update] An appeal that failed, and what I would do differently Replied, post #105 · Access › Insurance & coverage · 14 Jun 2025 · 0 likes The arithmetic on appeal is the easy part and it is where the errors are, which is an uncomfortable combination. Show your working and someone will catch it.
-
The CagriSema phase 2 paper and what a fixed combination buys — the long version Replied, post #73 · Compounds › Cagrilintide & amylin analogues · 12 Jun 2025 · 12 likes Picking up post #72: that is the part I would want checked first. Combination products complicate the certificate question considerably. Two active components mean two…
-
Antibiotics and a course of something with delayed emptying Replied, post #59 · Practice › Interactions · 7 Jun 2025 · 4 likes Antibiotics is a question about a distribution, not about a value, and treating it as a value is what produces the confident wrong answers.
-
Splitting a vial for two laboratories: how to do it without ruining both Replied, post #55 · Sourcing › Independent verification · 5 Jun 2025 · 0 likes A note on how splitting a vial gets discussed rather than on splitting a vial itself: the confident posts get the replies and the careful ones get ignored, and the…
-
Checking someone else's arithmetic: a worked example thread Replied, post #47 · Practice › Reconstitution · 13 May 2025 · 25 likes Do not shake. Swirl, or leave it. Vigorous agitation introduces air and shear, and neither helps a peptide go into solution any faster than patience does. Old habit: I…
-
A well-designed study with a badly written abstract Replied, post #60 · Evidence › Study critique · 4 May 2025 · 21 likes Appreciated. The plain phrasing does more work here than a longer post would.
-
A page that has drifted out of date and needs a maintainer Replied, post #98 · Documentation › Wiki requests · 3 May 2025 · 0 likes Requests for a page summarising a supplier are declined, because that is what the vendor documentation set is for and it has its own standards. The variance between…
-
[2026 update] US compounding rules and how they changed Replied, post #11 · Regional › North America · 2 May 2025 · 27 likes The public assessment documents published at approval are free, detailed and largely unread here.
-
Second pass at: Retatrutide mass and identity: what a report should show Replied, post #32 · Compounds › Retatrutide · 30 Apr 2025 · 0 likes Answering the Retatrutide mass and identity question as asked, then the question I think is meant. As asked: yes, with the qualification below. As meant: it depends on…
-
Second pass at: Triple agonism: additive, synergistic, or neither? Replied, post #25 · Compounds › Retatrutide · 14 Mar 2025 · 0 likes Marking my uncertainty on Triple agonism explicitly. I am confident about the direction, much less confident about the size, and not confident at all that it…
-
Journal club: SURMOUNT-4 and continuation versus withdrawal — a second dataset Replied, post #2 · Evidence › Journal club · 11 Mar 2025 · 0 likes The opening post describes the usual case. This is about the unusual one. The documentation on SURMOUNT-4 and continuation versus withdrawal is better than this thread…
-
Obstructive sleep apnoea and a hard endpoint in this class Replied, post #22 · Clinical › Comorbidities · 26 Feb 2025 · 24 likes Everything in post #18 holds. The case it does not cover is the one I have. Obstructive sleep apnoea: SURMOUNT-OSA used an objective endpoint, the apnoea-hypopnoea…
-
Semaglutide in people without diabetes: what the evidence base looks like Replied, post #7 · Compounds › Semaglutide · 20 Feb 2025 · 18 likes The SELECT trial changed the positioning because it was the first cardiovascular outcome trial in people without diabetes. That decoupled the cardiovascular argument…
-
When "no data" is the complete and final answer Replied, post #96 · Compounds › Other compounds · 18 Feb 2025 · 0 likes Thymosin alpha-1 has a regulatory history in several jurisdictions and a real clinical literature, which puts it in a different evidential category from most of its…
-
Adducts: sodium, potassium, and the peak you did not expect Replied, post #13 · Analytics › Mass spectrometry · 17 Feb 2025 · 0 likes The honest summary of what a mass result buys you: it narrows the field of what the material could be, considerably. It never closes it, and no certificate should be…
-
Introducing myself and asking whether my planned first topic belongs anywhere Replied, post #4 · Start Here › Welcome · 9 Feb 2025 · 7 likes Worth knowing early: the archive is not retrospectively corrected. A topic from two years ago was accurate when written and may not be now. Every post carries its date…
-
Second pass at: Manufacturer assistance programmes and their eligibility rules Replied, post #2 · Access › Pricing · 27 Jan 2025 · 2 likes The arithmetic on Manufacturer assistance programmes is the easy part and it is where the errors are, which is an uncomfortable combination. Show your working and…
-
Reporting a good result: why nobody bothers and why they should — one year on Replied, post #21 · Sourcing › Vendor reports · 9 Jan 2025 · 0 likes This follows post #19 rather than contradicting it. Do not adjust a reported figure. Post what the laboratory said and put your interpretation in a separate sentence. I…
-
Oral semaglutide bioavailability and its variability between people — a second dataset Replied, post #82 · Compounds › Oral incretins · 27 Dec 2024 · 5 likes Anyone comparing published oral and injectable efficacy should check whether the comparison is within one trial or across two. Across two, the populations differ and…
-
Oral semaglutide bioavailability and its variability between people — a second dataset Replied, post #53 · Compounds › Oral incretins · 26 Dec 2024 · 1 like Post #51 is the version of this I will quote in future. One addition. Trial adherence in an oral trial with strict administration requirements is genuinely worse than…
-
Follow-up: Tirzepatide's shorter half-life and its one practical consequence Replied, post #108 · Compounds › Tirzepatide · 25 Dec 2024 · 25 likes I had written a reply contradicting post #106 and deleted it. Here is what survived. Categorical response thresholds — the proportion reaching ten, fifteen or twenty…
-
Revisiting: Bug report: the reconstitution calculator and a rounding edge case Replied, post #29 · Data & Tools › Calculators · 24 Dec 2024 · 4 likes Post #27 describes the usual case. This is about the unusual one. Do the arithmetic by hand the first few times, whatever tool you use afterwards. A calculator with a…
-
Oxidation and deamidation mass shifts, tabulated Replied, post #24 · Analytics › Mass spectrometry · 23 Dec 2024 · 15 likes Post #22 put the caveat in the right place and I want to underline it. Tandem mass spectrometry: MS/MS fragments the molecular ion and uses fragment masses to confirm…
-
Meeting a protein target on a suppressed appetite — does this still hold? Replied, post #49 · Nutrition & Training › Protein & intake · 10 Dec 2024 · 14 likes Confirming post #46 from a second method, which matters more than confirming it from a second person. Nothing here is medical or dietetic advice, and a dietitian is the…
-
Domestic fridge temperature mapping: a cheap experiment — what changed since Replied, post #19 · Devices › Cold chain · 8 Dec 2024 · 0 likes The thing about Domestic fridge temperature mapping that took me longest to accept is that a plausible mechanism is not evidence of an effect. It is a reason to look,…
-
What a stability-indicating method is and how you demonstrate one — one year on Replied, post #76 · Analytics › Method validation · 19 Nov 2024 · 15 likes Range: the concentration range over which the method has been validated. Going outside the validated range is going outside the method's demonstrated performance.
-
Reporting a good result: why nobody bothers and why they should — one year on Replied, post #5 · Sourcing › Vendor reports · 11 Nov 2024 · 12 likes Taking post #4 at face value and following it one step further. Pattern across lots: a single result is a data point. Three or four results from the same supplier…
-
US compounding rules and how they changed Replied, post #62 · Regional › North America · 8 Nov 2024 · 6 likes Say which country and which state or province. Regulatory position, availability and practical route can all differ within the same continent and frequently do. Take it…
-
Choosing which test to pay for, given a fixed budget — does this still hold? Replied, post #18 · Sourcing › Independent verification · 3 Nov 2024 · 14 likes Everything in post #16 holds. The case it does not cover is the one I have. It does not extend to lots nobody has seen, it is not a recommendation, and it says nothing…
-
A revision dispute resolved on the topic rather than in the history — a second dataset Replied, post #5 · Meta › Wiki maintenance · 9 Oct 2024 · 0 likes Flagging a stale cross-reference. This page links to a topic that was later promoted into its own document, so the link now goes to the discussion rather than the…
-
Semaglutide half-life: where the 165 to 184 hour figure comes from — what changed since Replied, post #15 · Compounds › Semaglutide · 24 Sep 2024 · 4 likes Post #13 describes the usual case. This is about the unusual one. Offering a way to settle Semaglutide half-life rather than another opinion about it. Two measurements,…
-
Reading a meta-analysis you disagree with, fairly Replied, post #13 · Evidence › Meta-analyses · 26 Aug 2024 · 15 likes Where I part company with post #9, and it is a narrow parting. Practical note on reading a meta-analysis: write down what you expect before you look. The number of…
-
Splitting a vial for two laboratories: how to do it without ruining both — what changed… Replied, post #18 · Sourcing › Independent verification · 26 Aug 2024 · 13 likes Small correction to my own earlier position on Splitting a vial. I had the units the wrong way round, which changes the conclusion by an order of magnitude and…
-
Correlation in a self-tracked dataset: what it can support Replied, post #146 · Research Methods › Statistics · 25 Aug 2024 · 28 likes Coming back to post #144, because the follow-up matters more than the original answer. I would rather this thread reach "we do not know" about correlation than reach a…
-
The C-cell question: rodent findings and their human context — what changed since Replied, post #17 · Compounds › Semaglutide · 22 Aug 2024 · 0 likes This follows post #16 rather than contradicting it. Taking c-cell question seriously for a moment rather than deflecting: the honest position is that the community has…
-
Follow-up: Where the four-week escalation interval comes from, and what it is not Replied, post #42 · Practice › Dosing & titration · 10 Aug 2024 · 2 likes Picking up post #39: that is the part I would want checked first. Careful with the language on four-week escalation interval. "Not detected" and "not present" are…
-
Guidelines revision: what changed and why Replied, post #116 · Meta › Announcements · 28 Jul 2024 · 6 likes Thank you for announcing it in advance rather than after. The number of places that do the reverse is remarkable. I would put this at better than even and not much…
-
Follow-up: Conditions that change the calculus rather than forbidding it Replied, post #25 · Safety › Contraindications · 23 Jul 2024 · 23 likes Confirming post #22 from a second method, which matters more than confirming it from a second person. A history of pancreatitis appears in the cautions and the decision…
-
Reading a meta-analysis you disagree with, fairly Replied, post #4 · Evidence › Meta-analyses · 7 Jul 2024 · 8 likes Having read the whole reading a meta-analysis thread before replying: the question in the first post has not actually been answered yet, and three of us have answered a…
-
Oral contraceptives and delayed emptying: what the data shows Replied, post #14 · Practice › Interactions · 7 Jul 2024 · 32 likes This follows post #13 rather than contradicting it. I have been on both sides of the oral contraceptives and delayed emptying argument in this category within eighteen…